Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio (teriflunomide)
European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio (teriflunomide)
European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio (teriflunomide)
Submitted by
admin
on August 31, 2013 - 11:13am
Source:
Yahoo/BusinessWire
News Tags:
Genzyme
multiple sclerosis
Aubagio
MS
Headline:
European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio (teriflunomide)
Do Not Allow Advertisers to Use My Personal information
